Accession Number : ADA328029

Title :   EGF Receptor Mabs and Chemotherapy in Breast Cancer.

Descriptive Note : Annual rept. 15 Sep 94-14 Sep-96,

Corporate Author : MEMORIAL SLOAN-KETTERING CANCER CENTER NEW YORK

Personal Author(s) : Norton, Larry ; Seidman, Andrew

PDF Url : ADA328029

Report Date : OCT 1996

Pagination or Media Count : 12

Abstract : To establish a safety profile in patients with Stage IV, EGFr positive breast cancer, for which no curative standard exists, of C225 over a range of dose levels and to pharmacologically optimize the dosing regimen of loading and maintenance infusions administered during combination chemotherapy with weekly doses of paclitaxel.

Descriptors :   *CHEMOTHERAPY, *GROWTH(PHYSIOLOGY), *BREAST CANCER, PROFILES, SAFETY, DOSAGE, LEVEL(QUANTITY), MONOCLONAL ANTIBODIES, CURING AGENTS, RECEPTOR SITES(PHYSIOLOGY).

Subject Categories : Medicine and Medical Research

Distribution Statement : APPROVED FOR PUBLIC RELEASE